Low intensity light therapy for the manipulation of fibroblast-derived mammalian cells and collagen

Details for Australian Patent Application No. 2003220671 (hide)

Owner Light Bioscience, LLC.

Inventors McDaniel, David H.

Agent Shelston IP

Pub. Number AU-B-2003220671

PCT Number PCT/US03/10509

PCT Pub. Number WO2003/086215

Priority 10/119,772 11.04.02 US

Filing date 8 April 2003

Wipo publication date 27 October 2003

Acceptance publication date 1 May 2008

International Classifications

A61B 18/20 (2006.01) Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body - using laser

A61K 41/00 (2006.01) Medicinal preparations obtained by treating materials with wave energy or particle radiation

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 10/119,772 11.04.02 US

4 December 2003 Application Open to Public Inspection

  Published as AU-B-2003220671

25 November 2004 Amendment Made

  The nature of the amendment is: Amend the name of the applicant/patentee from Light Biosciences, Inc. to Light Biosciences, LLC.

1 May 2008 Application Accepted

  Published as AU-B-2003220671

28 August 2008 Standard Patent Sealed

24 December 2009 Assignment Registered

  Light Bioscience, LLC. The patent has been assigned to Gentlewaves LLC

18 February 2010 Alteration of Name

  The name of the has been altered to GentleWaves LLC

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003220672-METHOD AND APPARATUS FOR DE- TERMINING PROPERTIES OF A TEST MATERIAL BY SCRATCH TESTING

2003220670-OIL-FILLED NANOCAPSULES FROM MICROEMULSIONS UTILIZING CROSS-LINKABLE SURFACTANTS